Investing-News.Com
Information for Investors

Hemispherx - Investing-News.Com
 

 Home   Market News   Analysis   Commentary   Education   Tools   Weekly Report 

Internet Search   Stock Search
   


Hemispherx Related

Hemispherx Biopharma Developing specially-configured ribonucleic acid (RNA) to treat chronic fatigue syndrome (CFS), HIV associated disorders, chronic hepatitis B infection, and some cancers.
ALFERON N Injection for Genital Warts -- Hemispherx Biopharma, Inc. Hemispherx Biopharma, Inc. ... contained on the Hemispherx website other than ... and operations of Hemispherx involve risks of competition, ...
HEB: Summary for HEMISPHERX BIOPHARMA - Yahoo! Finance Get detailed information on Hemispherx BIOPHARMA (HEB) including quote ... Hemispherx Biopharma Announces New Chief Financial Officer GlobeNewswire(Thu, Dec 4) ...
Asensio & Company: War Stories Hemispherx The Hemispherx Story. Hemispherx is a 34-year-old alleged drug company ... Hemispherx was one of Stratton's last fraudulent initial public offerings ("IPO" ...
Hemispherx Biopharma Introduces Expense Reduction Program: Financial ... PHILADELPHIA, Nov. 28, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. ... Hemispherx's flagship products include Alferon N Injection(r) (FDA approved for ...

Sponsored Links:
Analyst Calls It "A Stock Pickers Dream Come True" Our Best Selling Software Finds Growth & Momentum With Just 1 Click. New Software Offers "One-Click" Stock Picks. The StockPickerRT will pick stocks for you every trading day based on earnings, volume & momentum.
Click Here & Learn To Pick Winners In An Uncertain Market
How To Buy Low & Sell High Every Time Guaranteed The Position Cost Averaging Stock Investing Systems helps LONG-TERM investors buy low and sell high every time guaranteed. Click Here To Learn More Long Term Strategy Guarantees "Buy Low & Sell High". Learn More
"Precision Entry & Exit Points On Every Stock In Your Portfolio" California Developer Offers Solutions For High Tech Traders. This software is specially designed to give precision entry and exit points on AUTODESK, or any other stock you choose.
Click Here to learn how to take control of your trading.
"The Web's Best Desktop Financial Portal" The smartest traders on the web get all the content they need, without all the ads they don't and its FREE.

     Additional Links:
www.hemispherx.net/content/investor/filings/r10k-1231_01.txt ... over the entire process through an elaborate "systems" management approach. ... In February 1993, Hemispherx presented results of its Phase II study of Ampligen ...
SECURITIES AND EXCHANGE COMMISSION Hemispherx business strategy is designed around seeking the required regulatory ... and manufacture of drug products utilizing advanced drug delivery systems. ...
HEB: Summary for HEMISPHERX BIOPHARMA - Yahoo! Finance Investing Ideas. Expert Advice. Special Editions. Company Finances. Providers. Personal Finance ... and daily updates provided by Commodity Systems, Inc. ( CSI) ...
Analyst Reports for LSB Industries Inc., Imperial Oil Limited ... Analyst Reports for LSB Industries Inc., Imperial Oil Limited, Telephone and Data Systems Inc. and Hemispherx Biopharma Inc.. - LONDON--(MARKET WIRE)--Sep 10, ...
Hemispherx Biopharma, Inc. Company Profile - Yahoo! Finance Investing Ideas. Expert Advice. Special Editions. Company Finances ... Diversified Computer Systems. Diversified Investments. Drug Manufacturers - Major ...


Hemispherx Headlines

Hemispherx wins court victory in fraud case (Philadelphia Business Journal) Hemispherx Biopharma Inc. said Monday the U.S. Federal Court of Appeals overturned a lower court's dismissal of the company’s fraud claims against a group of South African business entities.
U.S. Court of Appeals Supports Hemispherx in Rebuff of Hostile Takeover Attempt (GlobeNewswire via Yahoo! Finance) PHILADELPHIA, Jan. 5, 2009 -- Hemispherx Biopharma, Inc. today announced that its position with respect to alleged illegal manipulation of its stock by foreign business entities for purposes of bringing about a hostile takeover of the Company has been upheld by the U.S.
US firm to sue JCI & Kebble (News 24 South Africa) Brett Kebble's estate and mining house JCI look set to face damage claims from US biotechnology company Hemispherx Biopharma.

Related Searches: investor penny stock successful  supertrader  merck vs integra case  online otc trading  struggling mercedes drags daimler s profit lower. 

Research Home


Article Search


Advanced Search

StreetInsider Alerts

Latest Headlines

  Place Our Content On Your Site!  rss Powered By The Investing System Network
© 2006 Investing-News.Com, All Rights Reserved.